Taro-carbamazepine (2020-01-29)
Taro-Carbamazepine Recall Summary Taro-Carbamazepine, an anti-seizure and nerve pain medication, was recalled across Canada in January 2020 due to product safety concerns. The recall was classified as Class I, meaning the product could cause serious health problems or death. This recall affected carbamazepine products distributed by Taro throughout Canada.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-01-29
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/cdd366b4-9100-4f2d-8cef-baa4d70b8472